我們改變生活
和系統
過去五年，世界衛生組織新發佈的指引中，有三分之二至少引用了一篇考科藍文獻回顧。了解我們的影響力。
我們的實證
值得信賴
科學家、政策制定者和決策者都依賴我們提供可信的證據。了解為什麼我們的證據值得信賴。
我們攜手
全球合作
我們透過與各領域專家及大眾成員的合作，產出卓越的證據。加入我們。
News
Common gout drug may reduce risk of heart attack and stroke
12 十一月 2025
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
Setting the standards for responsible AI use in evidence synthesis
11 十一月 2025
Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence have published a joint position statement on the responsible use of artificial intelligence (AI) in evidence synthesis.
GLP-1 drugs effective for weight loss, but more independent studies needed
30 十月 2025
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.
What is Cochrane doing to strengthen research integrity?
29 十月 2025
We continue to lead the field in trustworthiness and transparency by evolving our practices to address the most pressing challenges in research integrity and publishing ethics, and to respond to rapid advances in technology. Here is a wrap up of recent developments in these areas.
考科藍有何獨特之處？
了解我們獨特的健康證據、運作方式及所帶來的影響。
需要客製化證據服務嗎？
我們為所有使用健康證據的人士提供工具、數據和客製化服務。
正在撰寫考科藍文獻回顧嗎？
正在尋找撰寫文獻回顧的指引嗎？有興趣成為考科藍作者嗎？
我知道考科藍的系統性文獻回顧可靠、公正且無利益衝突，且會定期更新。那正是我所需要的，能讓我擺脫混亂、逸事和情緒的東西。〞
考科藍幫助我照顧自己，也幫助更多人……考科藍圖書館提供您可靠且最新的資訊，讓您成為更聰明、更積極參與自己健康的病人。〞
- 豐富我們的證據：成為同儕審查者
